The Human Story, As Told By Our Genomes
A Hong Kong-based molecular diagnostics laboratory founded by world-class scientists, delivering clinically accredited genomic testing since 2013.
Our Mission
To digitise healthcare management in Asia and accelerate diagnostic, treatment, and management processes through our integrated CoGenesis® assays and platform — empowering clinicians with genomic insights at the point of care.
Our Vision
To become the key enabler of precision medicine in Asia — pushing the boundaries of healthcare and providing broad access to genomic technologies for every patient who needs them.
Our Story
The Codex Genetics founding team first met during a research collaboration in 2008 — scientists with world-class training at Oxford, UCSF, Washington University in St. Louis, and CUHK. Driven by a shared belief that genomics could fundamentally change how diseases are diagnosed and treated, they founded Codex Genetics in Hong Kong in 2013.
Based at Hong Kong Science Park, we have grown from a pioneering bioinformatics start-up into a full-service clinical molecular diagnostics laboratory. Today, we offer 41 accredited diagnostic tests spanning hereditary cancer, neurodegenerative disease, oncology, pharmacogenomics, and rare disease — processing over 10,000 cases per year for hospitals, clinicians, and research organisations across the region.
Our proprietary CoGenesis® platform — backed by ITC-funded research and deployed at Novartis and leading local hospitals — combines NLP-powered clinical data curation, an accredited genomics analytics portal, and intelligent clinical trial matching to deliver actionable insights at scale.
As exclusive Hong Kong distributors for Guardant Health and Pacific Edge, we bring the world's most clinically validated liquid biopsy and genomic tests directly to our patients and healthcare partners.
Our Milestones
Portfolio expanded to 41 diagnostic tests across 23 clinical areas. ISO 15189 HOKLAS accreditation maintained. Expanding presence in Greater Bay Area.
Exclusive partnership with Pacific Edge — bringing cxBladder genomic bladder cancer tests to Hong Kong.
Exclusive partnership with Guardant Health — bringing FDA-approved liquid biopsy and ctDNA tests to Hong Kong.
Designated as an ITC Local Research Institution (DLRI). Passed GenQA / UK NEQAS EQA for Next Generation Sequencing.
Completion of ISO-ready clinical molecular diagnostics laboratory at Hong Kong Science Park.
Winner of the Spirit of Hong Kong Best Innovation Award.
Secured ~USD 4M Series A funding. Launched CoGenesis® ClinMatch in collaboration with Novartis for NSCLC precision clinical trial — 200+ patients enrolled.
Accepted into HKSTP InCu-Tech incubation programme. Awarded ITF TSSSU grant for bioinformatics R&D.
Codex Genetics Limited founded in Hong Kong with a mission to enable precision medicine.
Founding team meets during research collaboration — scientists with Oxford, UCSF, WashU, and CUHK training.
Accreditations & Certifications
Independently verified to the highest international standards — so you can trust every result we deliver
ISO 15189 HOKLAS
Medical Laboratory Accreditation
Accredited laboratory (HOKLAS 869S) under ISO 15189 — the international standard for medical testing laboratories. Guarantees the technical competence and quality of our diagnostic results.
ISO/IEC 27001:2022
Information Security Management
Our ISMS meets international standards for confidentiality, integrity, and availability of all patient data and clinical information — including compliance with HIPAA and HK PDPO.
GenQA / UK NEQAS
External Quality Assurance — NGS
Passed the internationally recognised GenQA EQA scheme for Next Generation Sequencing (2021+), conducted by UK NEQAS. Also passed the College of American Pathologists EQA for APOE genotyping.
ITC Designated Local Research Institution
Government-recognised Research Credibility
Designated by the Innovation and Technology Commission (ITC) as a Designated Local Research Institution — recognising Codex's scientific rigour and contribution to Hong Kong's innovation ecosystem.
Leadership Team
Led by scientists and engineers trained at the world's top institutions
Aldrin Yim
Chief Executive Officer
PhD, CUHK
Aldrin leads Codex Genetics' strategic vision and business development. With deep expertise in molecular diagnostics and precision medicine, he has driven the company's growth from a research start-up to a leading clinical genomics laboratory trusted by hospitals and clinicians across Hong Kong.
Allen Yu
Chief Technology Officer
PhD, Washington University in St. Louis · Chevening Scholar
Allen oversees the CoGenesis® bioinformatics platform and computational infrastructure. Trained at WashU with a Chevening Scholarship, he brings world-class expertise in genomic data science, natural language processing, and clinical informatics to transform raw genomic data into actionable clinical insights.
Prof. T.F. Chan
Chief Scientific Officer
MSc, Oxford · Associate Professor, CUHK · Director, HK Bioinformatics Centre
Professor Chan provides scientific leadership and academic rigour across all Codex research programmes. As Director of the Hong Kong Bioinformatics Centre and Associate Professor at CUHK, he bridges cutting-edge academic research with clinical application, ensuring Codex's methods remain at the frontier of genomic science.
Our Capabilities
A fully integrated platform — from laboratory testing to clinical decision support
Clinical NGS & WGS
Whole genome, whole exome, and targeted gene panel sequencing for hereditary disease, cancer, and rare conditions. 99.9%+ analytical accuracy.
Liquid Biopsy & Biomarker Testing
ctDNA profiling, cell-free DNA analysis, plasma protein biomarkers, and epigenomic panels for cancer screening, MRD monitoring, and treatment guidance.
Neurodegenerative Biomarkers
Blood-based p-tau217, p-tau181, GFAP, NfL, α-Synuclein SAA, and exclusive PrecivityAD2™ for Alzheimer's disease diagnosis per NIA-AA 2024 guidelines.
CoGenesis® Bioinformatics Platform
Proprietary NLP-powered clinical informatics platform for genomic data analytics, patient registry management, and clinical trial eligibility matching.
Clinical Research & Trial Management
End-to-end clinical trial support — from protocol design and patient recruitment to regulatory-grade genomic reporting and data management.
Exclusive Distribution Partnerships
Exclusive Hong Kong distributor for Guardant Health (liquid biopsy) and Pacific Edge (cxBladder) — bringing globally proven diagnostic technologies to local clinicians.
Trusted By
Partnering with leading hospitals, government bodies, research institutions, and global diagnostics companies
Work With Codex Genetics
Whether you are a hospital, research institution, clinician, or industry partner — we would love to explore how we can collaborate.
Hong Kong-based molecular diagnostics laboratory specialising in clinical genomics, precision oncology, and rare disease diagnosis. Accredited to ISO 27001 and GenQA standards.
© 2026 Codex Genetics Limited. All rights reserved.
